As of 2026-08-24, Genomics & Precision-Medicine Tools ranks №2 among themes for that session with a composite score of 72/100 and median member RS of 95.
Composite
72/100
Median RS
95
Breadth > 50dma
78%
% at Highs
22%
Accumulation
67%
$-Vol Δ
+8%
Score history · last 60 sessionsLast 72·Range 60–93
Members9 tickers
Ticker / whyRSTrendHighAccum$Vol
TWSTTwist manufactures synthetic DNA, genes, oligo pools, and next-generation-sequencing preparation and analysis products.
RS 99
50D
--
ACCUM
+24%$254.2M / $205.5M
TXG10x Genomics provides instruments, consumables, and software for single-cell and spatial gene-expression analysis.
RS 99
50D
--
--
+41%$238.8M / $169.0M
ABCLAbCellera operates a technology platform combining single-cell screening, computation, and wet-lab capabilities to discover precision antibody medicines.
RS 98
50D
--
ACCUM
-25%$69.9M / $93.4M
PSNLPersonalis provides advanced genomic sequencing and tumor-informed testing for precision oncology and cancer recurrence monitoring.
RS 98
50D
--
ACCUM
+54%$81.8M / $53.2M
ILMNIllumina supplies sequencing instruments, consumables, software, and services used to analyze genetic variation and function.
RS 95
50D
HIGH
ACCUM
+20%$502.4M / $417.3M
GHGuardant develops blood-based genomic tests and data products for cancer screening, recurrence monitoring, and treatment selection.
RS 94
50D
--
ACCUM
-1%$361.0M / $363.9M
NTRANatera develops cell-free-DNA and genetic tests across oncology, women's health, and organ health.
RS 93
50D
HIGH
--
-9%$399.7M / $437.0M
VCYTVeracyte develops genomic diagnostic tests and a distributed testing platform for cancer diagnosis and treatment decisions.
RS 54
--
--
--
-27%$48.3M / $66.4M
PACBPacific Biosciences develops long-read and short-read sequencing systems, consumables, and analysis tools.